📰 Trinity Biomedical Sciences News
Trinity Biomedical Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trinity Biomedical Sciences. Real-time updates on events, politics, business and more.
August 21, 2023
MC Hammer has given the thumbs up to Trinity College Dublin research that could help in the battle against Alzheimer’s.
June 13, 2022
Trinity College Dublin researchers have created luminescent, self-healing gels with a variety of potential applications ranging from counterfeiting bank notes to next-generation bio-sensing and imaging.
March 15, 2022
The SARM1 gene is a key driver in the damage that ultimately leads to impaired vision
March 4, 2022
From agritech to mental health, these eight campus start-ups were celebrated for their work at the Trinity Innovation Awards.
March 3, 2022
An ambitious academic, clinical and industry research programme that will provide new insights in our understanding of Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), was launched in Trinity by Tánaiste and Minister for Enterprise, Trade and Employment, Leo Varadkar. The programme will result in advanced data-driven prediction models for progression of the disease in patients and next-generation data analysis that facilitates clinical insights and treatment.
March 2, 2022
An ambitious academic, clinical and industry research programme that will provide new insights in our understanding of Motor Neuron Disease (MND), also known as Amyotrophic Lateral Sclerosis (ALS), was launched in Trinity today by Tánaiste and Minist
March 1, 2022
The programme will result in advanced data-driven prediction models for progression of the disease in patients and next-generation data analysis that facilitates clinical insights and treatment. This unique programme brings together clinicians, computer scientists, information engineers, technologists, and data scientists.
February 18, 2022
The SARM1 gene is a key driver in the damage that ultimately leads to impaired vision
February 17, 2022
The research suggests therapies targeting a gene could lead to new treatment options for many forms of blindness.